Basis: Trailing twelve months (TTM). Source: stored company filings and market data; unavailable inputs remain N/A.
Is the earnings per share (EPS) high or low?
The earnings per share (EPS) of 5.36 is 215% above its 5-year average of -4.68, near the high end of its 5-year range (-28.05–5.48).
585.07% above its 12-month average of -1.10.
Reported quarterly EPS; no daily interpolation. Q2 FY2026 (2026-06-28): 1.37.
EPS growth vs the same fiscal quarter in the prior fiscal year, last 40 comparable quarters.
FMP quote price / unrounded diluted EPS from four consecutive issuer fiscal quarters Quote observation: 2026-10-02T20:25:37.238Z. Historical observations retain their original dates. Historical series through 2026-10-01.
EARNINGS PER SHARE (EPS)
5.36
EARNINGS PER SHARE (EPS) AVG TTM
-1.10
EARNINGS PER SHARE (EPS) AVG 3Y
-9.40
EARNINGS PER SHARE (EPS) AVG 5Y
-4.68
EARNINGS PER SHARE (EPS) AVG 10Y
-0.39
EARNINGS PER SHARE (EPS) AVG 15Y
3.49
EARNINGS PER SHARE (EPS) AVG 20Y
2.44
CURRENT VS TTM AVG
+585.07%
CURRENT VS 3Y AVG
+157.01%
CURRENT VS 5Y AVG
+214.57%
CURRENT VS 10Y AVG
+1461.66%
CURRENT VS 15Y AVG
+53.79%
CURRENT VS 20Y AVG
+119.52%
Illumina, Inc.
Market Cap
$41.31B
Earnings Per Share (EPS)
5.36
TTM Avg
-1.10
3Y Avg
-9.40
5Y Avg
-4.68
Market Cap
$40.89B
Earnings Per Share (EPS)
14.12
TTM Avg
11.97
3Y Avg
10.56
5Y Avg
9.63
Market Cap
$41.75B
Earnings Per Share (EPS)
4.01
TTM Avg
10.78
3Y Avg
11.05
5Y Avg
10.65
Market Cap
$42.50B
Earnings Per Share (EPS)
8.06
TTM Avg
7.74
3Y Avg
7.17
5Y Avg
5.87
Market Cap
$46.04B
Earnings Per Share (EPS)
0.60
TTM Avg
-0.11
3Y Avg
-0.73
5Y Avg
-1.03
Market Cap
$46.63B
Earnings Per Share (EPS)
10.56
TTM Avg
9.94
3Y Avg
15.54
5Y Avg
18.41
Market Cap
$47.38B
Earnings Per Share (EPS)
5.08
TTM Avg
4.52
3Y Avg
4.36
5Y Avg
3.96
Market Cap
$48.72B
Earnings Per Share (EPS)
3.32
TTM Avg
5.86
3Y Avg
5.65
5Y Avg
5.38
Market Cap
$49.03B
Earnings Per Share (EPS)
1.74
TTM Avg
4.41
3Y Avg
3.40
5Y Avg
2.89
| NAME | MARKET CAP | EARNINGS PER SHARE (EPS) | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Illumina, Inc. (ILMN) | $41.31B | 5.36 | -1.10 | -9.40 | -4.68 |
| IDEXX Laboratories, Inc. (IDXX)vs › | $40.89B | 14.12 | 11.97 | 10.56 | 9.63 |
| Waters Corporation (WAT)vs › | $41.75B | 4.01 | 10.78 | 11.05 | 10.65 |
| IQVIA Holdings Inc. (IQV)vs › | $42.50B | 8.06 | 7.74 | 7.17 | 5.87 |
| Teva Pharmaceutical Industries Limited (TEVA)vs › | $46.04B | 0.60 | -0.11 | -0.73 | -1.03 |
| Humana Inc. (HUM)vs › | $46.63B | 10.56 | 9.94 | 15.54 | 18.41 |
| Agilent Technologies, Inc. (A)vs › | $47.38B | 5.08 | 4.52 | 4.36 | 3.96 |
| Becton, Dickinson and Company (BDX)vs › | $48.72B | 3.32 | 5.86 | 5.65 | 5.38 |
| Edwards Lifesciences Corporation (EW)vs › | $49.03B | 1.74 | 4.41 | 3.40 | 2.89 |
| Biogen Inc. (BIIB)vs › | $32.49B | 5.65 | 10.02 | 12.26 | 14.06 |
Trailing EPS (TTM)
$5.36
Forward EPS (Est.)
$5.35
P/E Ratio
50.9
Formula: EPS = Net Income / Weighted Average Shares Outstanding
Why EPS matters:
EPS (Earnings Per Share) represents the portion of a company's profit allocated to each outstanding share. Higher EPS indicates greater profitability on a per-share basis.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | EARNINGS PER SHARE (EPS) |
|---|---|
| 2025-12-28 | 5.48 |
| 2024-12-29 | -7.69 |
| 2023-12-31 | -7.35 |
| 2023-01-01 | -28.05 |
| 2022-01-02 | 5.08 |
| 2021-01-03 | 4.46 |
| 2019-12-29 | 6.82 |
| 2018-12-31 | 5.62 |
| 2017-12-31 | 4.97 |
| 2016-12-31 | 3.15 |
| 2015-12-31 | 3.18 |
| 2014-12-31 | 2.61 |
| 2013-12-31 | 1.00 |
| 2012-12-31 | 1.23 |
| 2011-12-31 | 0.70 |
| 2010-12-31 | 1.01 |
| 2009-12-31 | 0.59 |
| 2008-12-31 | 0.43 |
| 2007-12-31 | -2.57 |
| 2006-12-31 | 0.45 |
| 2005-12-31 | -0.26 |
| 2004-12-31 | -0.09 |
| 2003-12-31 | -0.42 |
| 2002-12-31 | -0.65 |
| 2001-12-31 | -0.42 |
| 2000-12-31 | -0.33 |
| 1999-12-31 | -1.96 |
(FMP quote price / unrounded diluted TTM EPS) / five-year diluted EPS CAGR in percent, from annual statements through the period end shown Quote observation: 2026-10-02T20:25:37.238Z. Historical observations retain their original dates. Historical series through 2026-10-01.
